|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,365.00 GBX | -0.46% |
|
-2.01% | +26.24% |
| 12-11 | Experian on JPMorgan focus list at 'overweight' | AN |
| 12-01 | JPMorgan cuts easyJet; Barclays raises Reckitt | AN |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.48 | 8.26 | 8.25 | 8.27 | 9.64 | |||||
Return on Total Capital | 10.47 | 10.25 | 10.17 | 10.12 | 11.88 | |||||
Return On Equity % | 13.01 | 15.78 | 15.07 | 14.47 | 19.64 | |||||
Return on Common Equity | 13.13 | 15.81 | 15.11 | 14.5 | 19.69 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 36.63 | 36.98 | 45.67 | 46.45 | 46.69 | |||||
SG&A Margin | 22.16 | 21.56 | 17.46 | 17.2 | 15.86 | |||||
EBITDA Margin % | 17.55 | 20.7 | 21.88 | 21.83 | 23.15 | |||||
EBITA Margin % | 16.38 | 19.68 | 20.81 | 20.76 | 22.22 | |||||
EBIT Margin % | 14.47 | 15.41 | 16.32 | 16.3 | 18.12 | |||||
Income From Continuing Operations Margin % | 8.85 | 9.42 | 9.86 | 9.53 | 12.17 | |||||
Net Income Margin % | 8.86 | 9.35 | 9.81 | 9.48 | 12.13 | |||||
Net Avail. For Common Margin % | 8.86 | 9.35 | 9.81 | 9.48 | 12.13 | |||||
Normalized Net Income Margin | 8.45 | 8.65 | 8.69 | 8.71 | 9.83 | |||||
Levered Free Cash Flow Margin | 6.62 | 9.51 | 10.86 | 9.48 | 17.79 | |||||
Unlevered Free Cash Flow Margin | 7.21 | 10.31 | 12.28 | 10.8 | 18.98 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.94 | 0.86 | 0.81 | 0.81 | 0.85 | |||||
Fixed Assets Turnover | 11.26 | 10.53 | 9.89 | 10.49 | 11.21 | |||||
Receivables Turnover (Average Receivables) | 8.75 | 7.76 | 7.34 | 7.4 | 7.54 | |||||
Inventory Turnover (Average Inventory) | 4.15 | 3.57 | 2.9 | 2.85 | 2.81 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.66 | 1.63 | 2.06 | 2.17 | 2.04 | |||||
Quick Ratio | 0.78 | 0.77 | 1.04 | 0.94 | 1.01 | |||||
Operating Cash Flow to Current Liabilities | 0.66 | 0.47 | 0.8 | 0.73 | 0.9 | |||||
Days Sales Outstanding (Average Receivables) | 41.7 | 47.03 | 49.7 | 49.47 | 48.42 | |||||
Days Outstanding Inventory (Average Inventory) | 87.92 | 102.13 | 125.97 | 128.53 | 129.68 | |||||
Average Days Payable Outstanding | 40.52 | 43.57 | 52.17 | 70.33 | 97.69 | |||||
Cash Conversion Cycle (Average Days) | 89.1 | 105.59 | 123.5 | 107.68 | 80.41 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 47.04 | 65.8 | 44.05 | 61.71 | 46.76 | |||||
Total Debt / Total Capital | 31.99 | 39.69 | 30.58 | 38.16 | 31.86 | |||||
LT Debt/Equity | 41.92 | 59.34 | 42.35 | 60.24 | 45.31 | |||||
Long-Term Debt / Total Capital | 28.51 | 35.79 | 29.4 | 37.25 | 30.88 | |||||
Total Liabilities / Total Assets | 44.99 | 51.54 | 43.25 | 49.51 | 45.05 | |||||
EBIT / Interest Expense | 15.19 | 11.92 | 7.23 | 7.72 | 9.49 | |||||
EBITDA / Interest Expense | 19.87 | 16.98 | 10.24 | 10.9 | 12.66 | |||||
(EBITDA - Capex) / Interest Expense | 19.21 | 15.89 | 9.44 | 10.24 | 12.2 | |||||
Total Debt / EBITDA | 1.71 | 1.98 | 1.43 | 1.76 | 1.26 | |||||
Net Debt / EBITDA | 1.54 | 1.79 | 1.21 | 1.58 | 1.04 | |||||
Total Debt / (EBITDA - Capex) | 1.77 | 2.11 | 1.55 | 1.87 | 1.31 | |||||
Net Debt / (EBITDA - Capex) | 1.59 | 1.91 | 1.31 | 1.68 | 1.08 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 46.25 | 28.63 | 18.51 | 13.59 | 11.82 | |||||
Gross Profit, 1 Yr. Growth % | 48.35 | 29.85 | 21.42 | 15.52 | 12.4 | |||||
EBITDA, 1 Yr. Growth % | 49.89 | 33.65 | 26.01 | 13.33 | 17.75 | |||||
EBITA, 1 Yr. Growth % | 47.6 | 34.94 | 26.16 | 13.29 | 18.8 | |||||
EBIT, 1 Yr. Growth % | 59.52 | 37.05 | 26.55 | 13.48 | 23.08 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 39.96 | 36.87 | 24 | 9.89 | 42.69 | |||||
Net Income, 1 Yr. Growth % | 41.58 | 35.67 | 24.29 | 9.86 | 43 | |||||
Normalized Net Income, 1 Yr. Growth % | 57.02 | 31.67 | 20.13 | 13.93 | 24.75 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 28.8 | 35.78 | 19.1 | 6.31 | 42.87 | |||||
Accounts Receivable, 1 Yr. Growth % | 54.46 | 39.01 | 15.49 | 10.39 | 9.15 | |||||
Inventory, 1 Yr. Growth % | 38.97 | 55.51 | 7.04 | 20.37 | 6.18 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 34.96 | 39.48 | 16.7 | -1.07 | 10.44 | |||||
Total Assets, 1 Yr. Growth % | 41.58 | 40.23 | 15.25 | 11.5 | 2.1 | |||||
Tangible Book Value, 1 Yr. Growth % | -126.17 | 133.01 | -59.98 | 141.15 | -65.81 | |||||
Common Equity, 1 Yr. Growth % | 1.76 | 23.44 | 35.29 | -0.85 | 11.45 | |||||
Cash From Operations, 1 Yr. Growth % | 35.95 | 7.67 | 51.36 | 4.7 | 35.08 | |||||
Capital Expenditures, 1 Yr. Growth % | -41.67 | 191.84 | 51.05 | -12.5 | -29.1 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -28.89 | 35.98 | 36.6 | -0.89 | 107.77 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -24.11 | 38.38 | 42.15 | -0.07 | 94.83 | |||||
Dividend Per Share, 1 Yr. Growth % | 42 | 26.29 | 5.02 | 4.96 | 5.06 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 20.23 | 37.15 | 23.47 | 16.02 | 12.7 | |||||
Gross Profit, 2 Yr. CAGR % | 20.99 | 38.8 | 37.87 | 18.43 | 13.95 | |||||
EBITDA, 2 Yr. CAGR % | 17.03 | 50.81 | 29.37 | 19.5 | 15.93 | |||||
EBITA, 2 Yr. CAGR % | 15.92 | 51.01 | 30.05 | 19.55 | 16.44 | |||||
EBIT, 2 Yr. CAGR % | 16.51 | 47.86 | 31.15 | 19.84 | 18.74 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 5.69 | 38.41 | 30.28 | 16.73 | 25.22 | |||||
Net Income, 2 Yr. CAGR % | 6.19 | 38.6 | 29.86 | 16.85 | 25.34 | |||||
Normalized Net Income, 2 Yr. CAGR % | 13.46 | 43.79 | 25.19 | 16.99 | 19.87 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 1.1 | 32.24 | 27.17 | 12.52 | 23.24 | |||||
Accounts Receivable, 2 Yr. CAGR % | 15.19 | 46.53 | 26.66 | 12.91 | 9.77 | |||||
Inventory, 2 Yr. CAGR % | 16.73 | 47 | 29.02 | 13.51 | 13.05 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 73.42 | 37.2 | 27.58 | 7.45 | 4.53 | |||||
Total Assets, 2 Yr. CAGR % | 40 | 40.9 | 27.13 | 13.36 | 6.7 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.78 | -21.91 | -3.43 | -1.76 | -9.2 | |||||
Common Equity, 2 Yr. CAGR % | 29.2 | 12.08 | 29.23 | 15.82 | 5.12 | |||||
Cash From Operations, 2 Yr. CAGR % | 28.51 | 20.98 | 27.66 | 25.89 | 18.93 | |||||
Capital Expenditures, 2 Yr. CAGR % | -28.93 | 30.48 | 109.96 | 14.96 | -21.24 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 10.38 | 14.63 | 35.71 | 16.35 | 44.22 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 14.74 | 18.16 | 39.71 | 19.19 | 40.16 | |||||
Dividend Per Share, 2 Yr. CAGR % | 21.2 | 33.92 | 15.16 | 4.99 | 5.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 17.52 | 22.97 | 30.64 | 20.08 | 14.6 | |||||
Gross Profit, 3 Yr. CAGR % | 18.6 | 23.88 | 41.28 | 29.98 | 16.39 | |||||
EBITDA, 3 Yr. CAGR % | 16.72 | 27.62 | 41.75 | 23.79 | 19.19 | |||||
EBITA, 3 Yr. CAGR % | 16.11 | 27.57 | 41.91 | 24.2 | 19.6 | |||||
EBIT, 3 Yr. CAGR % | 15.93 | 22.99 | 39.99 | 24.97 | 21.29 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 8.61 | 15.2 | 33.43 | 23.09 | 24.81 | |||||
Net Income, 3 Yr. CAGR % | 9.07 | 15.23 | 33.65 | 22.81 | 24.99 | |||||
Normalized Net Income, 3 Yr. CAGR % | 14.06 | 19.23 | 35.01 | 21.32 | 19.96 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 5.54 | 11.54 | 27.71 | 19.79 | 21.85 | |||||
Accounts Receivable, 3 Yr. CAGR % | 14.68 | 22.64 | 35.32 | 20.99 | 11.64 | |||||
Inventory, 3 Yr. CAGR % | 19.03 | 28.44 | 32.25 | 26.07 | 11.01 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 51.7 | 61.28 | 29.99 | 17.21 | 8.44 | |||||
Total Assets, 3 Yr. CAGR % | 34.47 | 40.08 | 31.77 | 21.69 | 9.48 | |||||
Tangible Book Value, 3 Yr. CAGR % | -12.17 | 35.89 | -37.51 | 31.02 | -30.9 | |||||
Common Equity, 3 Yr. CAGR % | 22.58 | 27.25 | 19.34 | 18.3 | 14.34 | |||||
Cash From Operations, 3 Yr. CAGR % | 21.15 | 21.15 | 30.36 | 19.5 | 28.88 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.58 | 13.81 | 37 | 56.83 | -2.14 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 1.1 | 31.06 | 21.19 | 22.21 | 41.64 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 4 | 34.29 | 25.34 | 24.94 | 40.82 | |||||
Dividend Per Share, 3 Yr. CAGR % | 18.66 | 22.87 | 23.49 | 11.66 | 5.01 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 15.53 | 17.52 | 19.86 | 20.14 | 23.14 | |||||
Gross Profit, 5 Yr. CAGR % | 16.02 | 18.38 | 25.96 | 26.31 | 29.64 | |||||
EBITDA, 5 Yr. CAGR % | 15.07 | 20.42 | 24.75 | 24.15 | 30.79 | |||||
EBITA, 5 Yr. CAGR % | 14.87 | 20.48 | 24.83 | 24.14 | 31.12 | |||||
EBIT, 5 Yr. CAGR % | 15.59 | 18.01 | 21.79 | 21.52 | 31.07 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.26 | 14.63 | 16.81 | 15.81 | 30.08 | |||||
Net Income, 5 Yr. CAGR % | 12.75 | 14.8 | 16.95 | 15.87 | 30.26 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15.4 | 16.37 | 18.39 | 18.11 | 28.74 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.54 | 12.57 | 13.71 | 11.93 | 25.9 | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.79 | 19.08 | 19.33 | 18.63 | 24.46 | |||||
Inventory, 5 Yr. CAGR % | 15.92 | 24.32 | 22.93 | 22.25 | 24.21 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 27.64 | 37.73 | 41.55 | 37.09 | 19.14 | |||||
Total Assets, 5 Yr. CAGR % | 23.47 | 30.42 | 31.49 | 28.71 | 21.1 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3 | 14.92 | -8.77 | 19.36 | -27.43 | |||||
Common Equity, 5 Yr. CAGR % | 18.09 | 20.37 | 25.19 | 22.55 | 13.43 | |||||
Cash From Operations, 5 Yr. CAGR % | 14.73 | 15.97 | 23.71 | 23.02 | 25.66 | |||||
Capital Expenditures, 5 Yr. CAGR % | 6.96 | 35.77 | 32.44 | 14.27 | 9.79 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.26 | 13.7 | 20.93 | 24.76 | 29.93 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 6.89 | 15.45 | 23.89 | 27.83 | 31.07 | |||||
Dividend Per Share, 5 Yr. CAGR % | 16.33 | 18.53 | 17.25 | 15.38 | 15.74 |
- Stock Market
- Equities
- DPLM Stock
- Financials Diploma PLC
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















